New Westminster, Canada Clinical Trials

A listing of New Westminster, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 112 clinical trials
Use of a Novel Digital Therapeutic Intervention for the Management of Delirium in the Critical Care Environment

Delirium is a condition of fluctuating confusion and agitation that affects as many as 80% of patients in critical care. Hyperactive delirium consumes a significant amount of clinical attention and resources due to the associated psychomotor agitation. Patients can become aggressive or combative putting both themselves and healthcare workers at …

  • 0 views
  • 29 May, 2021
  • 1 location
Assessing the Impact of the NeuroCatch Platform 2 Stimulus Tone Volume

The NeuroCatch Platform 2 (NCP2), an investigational medical device system developed by NeuroCatch Inc., consists of software and hardware that captures brain health information. The platform intends to provide a quick, portable and easy to use solution for the acquisition, display, analysis, storage, reporting and management of electroencephalograph (EEG) and …

HealthTech Connex Centre for Neurology Studies
 (3.7 away) Contact site
  • 0 views
  • 19 Jul, 2021
  • 1 location
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction

This study will assess whether an implantable defibrillator will increase the likelihood of survival in patients who have had a heart attack in the prior 5 years, have abnormal test results from a 24 hour heart monitor, and who have low normal heart function.

revascularisation
stemi
coronary angioplasty
ace inhibitor
coronary artery bypass graft
Fraser Clinical Trials
 (1.6 away) Contact site
  • 260 views
  • 21 Jan, 2021
  • +82 other locations
A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

This trial will enroll patients that have been diagnosed with a transient ischemic attack (TIA) or minor stroke that has occurred within the past 12 hours. Anyone diagnosed with a minor stroke faces the possibility of long-term disability and even death, regardless of treatment. Stroke symptoms such as weakness, difficulty …

angiography
computed tomography perfusion
deficit
ischemic stroke
ischemia
Royal Columbian Hospital
 (1.7 away) Contact site
  • 97 views
  • 26 Jan, 2021
  • +58 other locations
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

This is a Phase 3, open-label, multicenter extension study to evaluate safety and efficacy of ozanimod in subjects with moderately to severely active Crohn's Disease.

crohn's disease
remission
Fraser Clinical Trials Inc.
 (1.6 away) Contact site
  • 1037 views
  • 22 Feb, 2021
  • +807 other locations
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of guselkumab in participants with Crohn's disease.

ileocolitis
ileitis
fistulising crohn's disease
crohn's disease
abdominal pain
University of Washington
 (110.2 away) Contact site
  • 794 views
  • 07 Sep, 2021
  • +806 other locations
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.

crohn's disease
abdominal pain
remission
Fraser Clinical Trials Inc.
 (1.6 away) Contact site
  • 858 views
  • 23 Feb, 2021
  • +780 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
Fraser Clinical Trials Inc /ID# 169102
 (1.6 away) Contact site
  • 630 views
  • 26 Sep, 2021
  • +926 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

diabetes
myocardial infarction
stroke
infarct
acute coronary syndrome
1240068 - Fraser Clinical Trials, Inc.
 (1.6 away) Contact site
  • 1132 views
  • 26 Sep, 2021
  • +3432 other locations
Myocardial Ischemia and Transfusion

The purpose of this study is to compare two red blood cell transfusion strategies (liberal and restrictive) for patients who have had an acute myocardial infarction and are anemic.

blood transfusion
myocardial infarction
acute myocardial infarction
red blood cell transfusion
ischemia
Surrey Memorial Hospital
 (3.0 away) Contact site
  • 385 views
  • 02 Sep, 2021
  • +136 other locations